Curis
CRIS
#11033
Rank
ยฃ4.52 M
Marketcap
ยฃ0.68
Share price
6.65%
Change (1 day)
-31.94%
Change (1 year)

Operating Margin for Curis (CRIS)

Operating Margin as of November 2026 (TTM): -80.29%

According to Curis's latest financial reports and stock price the company's current Operating Margin is -80.29%. At the end of 2021 the company had an Operating Margin of -426.67%.

Operating Margin history for Curis from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-426.67%54.57%
2020-276.03%-14.08%
2019-321.28%2.85%
2018-312.39%-42.01%
2017-538.66%-32.88%
2016-802.59%7.21%
2015-748.64%293.46%
2014-190.27%131.64%
2013-82.14%-15.08%
2012-96.73%98.26%
2011-48.79%38.46%
2010-35.24%-69.87%
2009-116.94%-25.43%
2008-156.81%206.87%
2007-51.10%-24.1%
2006-67.32%-74.53%
2005-264.35%-16.21%
2004-315.48%251.65%
2003-89.72%-78.26%
2002-412.69%-94.52%
2001-7,534.60%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
22.64%-128.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-109.76% 36.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
42.68%-153.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-16,748.00% 20,759.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-388.94% 384.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
11.74%-114.62%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.